Exhibit 10.2
Separation Agreement and Release
This Separation Agreement and Release (“Agreement”) is made by and between David Mauney, M.D. (“Executive”) and Ziopharm Oncology, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
WHEREAS, the Parties have previously entered into that certain Employment Agreement, dated as of April 23, 2019 (the “Employment Agreement”);
WHEREAS, Executive’s employment with the Company and its subsidiaries terminated without Cause (as defined in the Employment Agreement) effective May 26, 2020 (the “Termination Date”);
WHEREAS, the Company and Executive have entered into a Consulting Agreement pursuant to which Executive will perform transitional consulting services following the Termination Date (the “Consulting Agreement”), subject to and in accordance with the terms thereof; and
WHEREAS, in connection with Executive’s termination of employment, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that Executive may have against the Company and any of the Releasees (as defined below) arising out of or in any way related to Executive’s employment with or separation from the Company or its subsidiaries or affiliates but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies in connection with Executive’s ownership of vested equity securities of the Company, Executive’s right to indemnification by the Company or any of its affiliates pursuant to contract or applicable law or Executive’s rights under the Consulting Agreement (collectively, the “Retained Claims”).
NOW, THEREFORE, in consideration of the severance payments and benefits described in Sections 9(b) and 10 of the Employment Agreement, which, pursuant to the Employment Agreement, are conditioned on Executive’s executionand non-revocation of this Agreement, and in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:
1. Severance Payments; Salary and Benefits. The Company agrees to provide Executive with the severance payments and benefits described in Sections 9(b) and 10 of the Employment Agreement, payable at the times set forth in, and subject to the terms and conditions of, the Employment Agreement. In addition, to the extent not already paid, and subject to the terms and conditions of the Employment Agreement, the Company shall pay or provide to Executive his accrued Base Salary through the Termination Date and expense reimbursement amounts for expenses incurred through the Termination Date. Executive shall also be entitled to reimbursement of reasonable attorney’s fees incurred by Executive in connection with the amicable negotiation of this Agreement and Executive’s Consulting Agreement up to $35,000, less any taxes that the Company reasonably determines it is required to withhold.
2. Release of Claims. Executive agrees that, other than with respect to the Retained Claims, the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company, any of its direct or indirect subsidiaries and affiliates, and any of their current and former officers, directors, equity holders, managers, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and successor corporations and assigns (collectively, the “Releasees”). Executive, on Executive’s own behalf and on behalf of any of Executive’s heirs, family members, executors, agents, and assigns, other than with respect to the Retained Claims, hereby and forever releases the Releasees from,
1